You are here: Home » News-CM » Companies » News
Business Standard

Granules India intimates of successful USFDA inspection of Gagillapur facility

Capital Market 

Located at Hyderabad, Telangana

announced that Company's Gagillapur facility located at Hyderabad, Telangana, has successfully completed US FDA inspection without any observations. This facility manufactures Finished Dosages (FDs) and Pharmaceutical Formulation Intermediates (PFIs).

Powered by Capital Market - Live News

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

RECOMMENDED FOR YOU

Granules India intimates of successful USFDA inspection of Gagillapur facility

Located at Hyderabad, Telangana

Located at Hyderabad, Telangana

announced that Company's Gagillapur facility located at Hyderabad, Telangana, has successfully completed US FDA inspection without any observations. This facility manufactures Finished Dosages (FDs) and Pharmaceutical Formulation Intermediates (PFIs).

Powered by Capital Market - Live News

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

image
Business Standard
177 22

Granules India intimates of successful USFDA inspection of Gagillapur facility

Located at Hyderabad, Telangana

announced that Company's Gagillapur facility located at Hyderabad, Telangana, has successfully completed US FDA inspection without any observations. This facility manufactures Finished Dosages (FDs) and Pharmaceutical Formulation Intermediates (PFIs).

Powered by Capital Market - Live News

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

image
Business Standard
177 22